Al Swarts is an accomplished pharmaceutical executive with deep expertise in technical operations, process development, and drug manufacturing. During his tenure at Amgen, he played a key role in scaling manufacturing processes and ensuring regulatory compliance across both small molecule and biologic programs. His core strengths include CMC strategy, supply chain optimization, and the integration of advanced technologies to improve efficiency and product quality throughout the development lifecycle.